Published in Ophthalmology on September 01, 2003
Repeat gas insufflation for successful closure of idiopathic macular hole following failed primary surgery. Indian J Ophthalmol (2014) 2.78
Re-operation of idiopathic full-thickness macular holes after initial surgery with internal limiting membrane peel. Br J Ophthalmol (2011) 1.20
A comparison of outcomes after indocyanine green and trypan blue assisted internal limiting membrane peeling during macular hole surgery. Br J Ophthalmol (2005) 0.98
Outcomes of 23-gauge pars plana vitrectomy and internal limiting membrane peeling with brilliant blue in macular hole. Clin Ophthalmol (2011) 0.89
A review of current management of vitreomacular traction and macular hole. J Ophthalmol (2015) 0.89
Comparison of anatomical and visual outcomes of macular hole surgery in patients with high myopia vs. non-high myopia: a case-control study using optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2011) 0.86
Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery. Graefes Arch Clin Exp Ophthalmol (2006) 0.83
Predictive value of preoperative optical coherence tomography for visual outcome following macular hole surgery: effects of imaging alignment. Jpn J Ophthalmol (2013) 0.82
Indocyanine green-assisted internal limiting membrane peeling in macular hole surgery: a meta-analysis. PLoS One (2012) 0.80
Chromovitrectomy: update. Saudi J Ophthalmol (2013) 0.79
[Macular hole. Survey and relevant surgical concepts]. Ophthalmologe (2005) 0.79
[Anatomical and functional results after elective macular surgery]. Ophthalmologe (2005) 0.79
Evaluation of secondary surgery to enlarge the peeling of the internal limiting membrane following the failed surgery of idiopathic macular holes. Exp Ther Med (2014) 0.78
Idiopathic macular hole: analysis of visual outcomes and the use of indocyanine green or brilliant blue for internal limiting membrane peel. Graefes Arch Clin Exp Ophthalmol (2013) 0.78
The effect of internal limiting membrane removal and indocyanine green on the success of macular hole surgery. Trans Am Ophthalmol Soc (2007) 0.77
Endoilluminator phototoxic maculopathy associated with combined ICG-assisted epiretinal membrane and internal limiting membrane peeling. Clin Ophthalmol (2014) 0.77
Long-term follow-up after vitrectomy to treat idiopathic full-thickness macular holes: visual acuity and macular complications. Clin Ophthalmol (2012) 0.77
Membrane peeling and indocyanine green. Ophthalmology (2004) 0.75
Complications of Macular Peeling. J Ophthalmol (2015) 0.75
The effect of autologous serum on vitrectomy with internal limiting membrane peeling for idiopathic macular hole. J Ocul Pharmacol Ther (2013) 0.75
Effect of internal limiting membrane abrasion on retinal tissues in macular holes. Invest Ophthalmol Vis Sci (2015) 0.75
Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J (2007) 3.65
Acute-onset floaters and flashes: is this patient at risk for retinal detachment? JAMA (2009) 2.82
Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol (2007) 2.73
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina (2008) 2.72
Evaluation of the clinical age-related maculopathy staging system. Ophthalmology (2006) 2.63
Techniques, rationale, and outcomes of internal limiting membrane peeling. Retina (2012) 2.50
Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J (2009) 2.37
Prevalence and significance of an isolated long QT interval in elite athletes. Eur Heart J (2007) 2.28
Utility of the "surprise" question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol (2008) 2.22
Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA (2013) 2.19
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol (2003) 2.10
Position paper: proposal for a core curriculum for a European Sports Cardiology qualification. Eur J Prev Cardiol (2012) 2.07
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol (2005) 1.98
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Retina (2006) 1.91
Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol (2011) 1.88
The right ventricle of the endurance athlete: the relationship between morphology and deformation. J Am Soc Echocardiogr (2011) 1.85
Health care economic analyses and value-based medicine. Surv Ophthalmol (2003) 1.83
Linking laboratory and pharmacy: opportunities for reducing errors and improving care. Arch Intern Med (2003) 1.76
Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med (2009) 1.75
Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol (2008) 1.74
Incremental cost-effectiveness of initial cataract surgery. Ophthalmology (2002) 1.72
Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol (2008) 1.71
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet (2004) 1.71
Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete's heart. Heart (2013) 1.68
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol (2005) 1.65
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol (2013) 1.54
Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation (2013) 1.53
Comparison of electrocardiographic criteria for the detection of cardiac abnormalities in elite black and white athletes. Circulation (2014) 1.53
Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation. Can J Ophthalmol (2010) 1.51
Clinical decisions. Cardiac screening before participation in sports. N Engl J Med (2013) 1.51
Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. Eur Heart J (2009) 1.50
Value-based medicine: evidence-based medicine and beyond. Ocul Immunol Inflamm (2003) 1.47
Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Arch Ophthalmol (2006) 1.42
Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria. Intern Emerg Med (2014) 1.41
Cost-utility analysis of cataract surgery in the second eye. Ophthalmology (2003) 1.41
Evaluating the cost-effectiveness of anterior uveitis investigation by Canadian ophthalmologists. Can J Ophthalmol (2008) 1.40
Support for inclusion of electrocardiography in addition to the Health Questionnaire and Physical Examination in athletic screening protocols for diagnosis of unsuspected hypertrophic cardiomyopathy. Am J Cardiol (2013) 1.39
Effect of small donor weight and donor-recipient weight ratio on the outcome of liver transplantation in children. Pediatr Transplant (2015) 1.38
Electrocardiographic interpretation in athletes: the 'Seattle criteria'. Br J Sports Med (2013) 1.34
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. Chem Biol (2007) 1.31
Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol (2002) 1.31
Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology (2003) 1.31
A cost-utility analysis of therapy for amblyopia. Ophthalmology (2002) 1.23
Small cell carcinoma of the esophagus: the Tata Memorial Hospital experience. Ann Thorac Surg (2002) 1.22
The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol (2006) 1.21
Cancer cell adaptation to chemotherapy. BMC Cancer (2005) 1.21
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol (2004) 1.19
The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc (2005) 1.18
Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol (2006) 1.17
Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women. AIDS Behav (2011) 1.17
Should axis deviation or atrial enlargement be categorised as abnormal in young athletes? The athlete's electrocardiogram: time for re-appraisal of markers of pathology. Eur Heart J (2013) 1.16
Tuberculosis in acute leukemia: a clinico-hematological profile. Hematology (2006) 1.14
Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience. Cancer Res (2013) 1.14
Environmental strategy and performance in small firms: a resource-based perspective. J Environ Manage (2007) 1.13
Interpretation of the electrocardiogram of young athletes. Circulation (2011) 1.10
Clinical significance of electrocardiographic right ventricular hypertrophy in athletes: comparison with arrhythmogenic right ventricular cardiomyopathy and pulmonary hypertension. Eur Heart J (2013) 1.09
Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient. Arch Ophthalmol (2008) 1.09
Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology (2006) 1.07
Versatility of the sural fasciocutaneous flap in the coverage of lower extremity wounds. Plast Reconstr Surg (2002) 1.07
Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration. Retina (2006) 1.06
Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg (2008) 1.06
The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J (2011) 1.05
Benign metastasizing meningioma. Jpn J Clin Oncol (2003) 1.05
Left ventricular hypertrophy in athletes. Eur J Echocardiogr (2009) 1.03
Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol (2006) 1.03
Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (2002) 1.03
Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Retina (2008) 1.02
Visual outcomes and complications of epiretinal membrane removal secondary to rhegmatogenous retinal detachment. Ophthalmology (2005) 1.02
Acute myocardial infarction in the presence of normal coronaries and the absence of risk factors in a young, lifelong regular exerciser. BMJ Case Rep (2009) 1.01
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol (2004) 1.01
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. J Med Chem (2007) 1.01
Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial. Radiology (2007) 1.00
Cardiovascular evaluation of middle-aged/ senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil (2011) 1.00
A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration. Ophthalmology (2007) 1.00
Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med (2010) 0.99
Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study. Can J Ophthalmol (2010) 0.99
Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP. Biochem J (2006) 0.99
Normal electrocardiographic findings: recognising physiological adaptations in athletes. Br J Sports Med (2013) 0.99
Surveillance of disparities in vision and eye health in the United States: an expert panel's opinions. Am J Ophthalmol (2012) 0.98
Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2010) 0.97
Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm (2010) 0.97
A cost-utility analysis of interventions for severe proliferative vitreoretinopathy. Am J Ophthalmol (2002) 0.97
Health insurance coverage and use of eye care services. Arch Ophthalmol (2008) 0.97
Fibromuscular dysplasia of the renal arteries: a radiological review. Int Urol Nephrol (2006) 0.96
Thoracic duct cyst of the mediastinum. Ann Thorac Cardiovasc Surg (2003) 0.96
Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur J Cancer (2004) 0.95
Primary colonic liposarcoma causing colo-colic intusussception: a case report and review of literature. J Gastrointest Cancer (2007) 0.95
Mediastinal haematoma: a rare complication following insertion of central venous catheter. Indian J Chest Dis Allied Sci (2011) 0.95
Quality of life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol (2002) 0.94
Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration. Curr Opin Ophthalmol (2011) 0.94
Coexisting pulmonary tuberculosis and mucormycosis in a patient with aplastic anemia post allogenic stem cell transplantation. Mediterr J Hematol Infect Dis (2011) 0.94
Preparticipation screening for cardiovascular abnormalities in young competitive athletes. BMJ (2008) 0.94